hanmi pharm 128940 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 128940 Date
Period 3 months 100-m won
2016.12 2017.12 2018.12 Average 2019.03 2019.06 2019.09 2019.12 2020.03 2020.06
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 8,827 9,166 10,160 9,384 2,746 2,704 2,657 3,029 2,976 3,038 2,784
O-profit 268 822 836 642 259 231 249 299 276 231 260
N-income 303 690 342 445 173 204 89 172 174 188 160
O-rate 3.0 9.0 8.2 6.7 9.4 8.5 9.4 9.9 9.3 7.6 9.3
N-rate 3.4 7.5 3.4 4.8 6.3 7.5 3.3 5.7 5.9 6.2 5.7
ROE 4.1 8.7 4.3 5.7 8.6 9.3 7.4 8.4 8.4 8.5 8.4
Debt-ratio 117.4 109.6 114.3 113.8 130.5 130.8 132.9 132.7 128.3 124.0 131.8
Quick-ratio 119.5 66.6 72.6 86.3 65.2 81.2 75.6 71.0 79.3 89.0 73.2
reserve-ratio 2,475.9 2,511.8 2,465.6 2,484.4 2,444.8 2,507.9 2,530.3 2,545.2 2,580.3 2,616.6 2,507.1
EPS 2,558 5,826 2,888 3,757 1,461 1,723 751 1,452 1,117 1,051 1,347
BPS 62,020 66,909 66,647 65,192 68,023 69,239 70,041 69,433 71,303 73,223 69,184
Dividends 0 472 481 318
2020-03-19
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ 132 %
High mid ~ 100 %
Mid ~ 67 %
Low mid ~ 35 %
Low price ~ 3 %
Indication price Range Current stock price Company score
445,093 W 445,093 W 373,325 W
373,325 W 373,325 W 301,557 W Evaluation
516,861 W 516,861 W~ 445,093 W
223,000 W
58.7301,557 W 301,557 W 229,789 W
Low price
Normal
229,789 W 229,789 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 36 3,122 988
229,789원
301,557원
373,325원
445,093원
516,861원
Low price
223,000원
3.%
35.2%
67.4%
99.6%
131.8%
0.%
20.%
40.%
60.%
80.%
100.%
120.%
140.%
0W
100,000W
200,000W
300,000W
400,000W
500,000W
600,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
hanmi pharm
Gap
hanmi pharm

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 128940 Date
Period
Gap
(Indication /
stock)
Color
2020-03-19
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
223,000 W Low price 52.9 Normal 8,000,000 W
Suggested Purchase
Amount 3,653,678 W
Number of stocks
purchased 16
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 516,861 W 516,861 W~ ~ 445,093 W 132 % -4,814,681 W All selling
High mid 445,093 W 445,093 W ~ 373,325 W 100 % -3,638,820 W -8
Mid 373,325 W 373,325 W ~ 301,557 W 67 % -2,462,959 W -7
Low mid 301,557 W 301,557 W ~ 229,789 W 35 % -1,287,098 W -4
low price 229,789 W 229,789 W ~ 0 W 3 % -111,237 W -0
Stock price rise
probability score
A Sector 49.6 45.3 50.8 50.4 45.8 48.4
52.9B Sector 47.1 29.6 35.8 50.4 43.3 20.8
Total average
2019.10.23 2019.11.20 2019.12.18 2020.01.20 2020.02.19 2020.03.18
48.3 37.4 43.3 29.2 44.6 34.6
35 % -29 %
2019.11.20 2019.12.18 2020.01.20 2020.02.19 2020.03.18
Total of
increase rate
Total score
A Sector -9 % 11 % -1 % -10 % 5 %
-12 % 40.0B Sector -59 % 17 % 29 % -16 % -108 %
Total average -29 % 14 % -49 %
50
45
51 50
46 4847
30
36
50
43
21
48
37
43
29
45
35
0
10
20
30
40
50
60
2019.10.23 2019.11.20 2019.12.18 2020.01.20 2020.02.19 2020.03.18
Stock price rise probability score
A sector
B sector
Total average
-9%
11%
-1%
-10%
5%
-59%
17%
29%
-16%
-108%
-29%
14%
-49%
35%
-29%
-120%
-100%
-80%
-60%
-40%
-20%
0%
20%
40%
60%
2019.11.20 2019.12.18 2020.01.20 2020.02.19 2020.03.18
Increase rate of stock price rise
A sector
B sector
Total average
hanmi pharm

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report